Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2008-07, Vol.22 (7), p.1446-1449
Hauptverfasser:	Stamatopoulos, K, Papadaki, T, Pontikoglou, C, Athanasiadou, I, Stavroyianni, N, Bux, J, Batsis, I, Pyrovolaki, K, Paterakis, G, Anagnostou, D, Anagnostopoulos, A, Papadaki, H A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal, Murine-Derived Antineoplastic Agents - adverse effects Apoptosis Biological and medical sciences Bone marrow Bone Marrow - pathology Bone Marrow - physiology Cancer Research Care and treatment Critical Care Medicine Cytokines - biosynthesis Diagnosis Female Genetic aspects Health aspects Hematologic and hematopoietic diseases Hematology Hematopoiesis Hematopoietic Stem Cells - physiology Histopathology Humans Intensive Internal Medicine letter-to-the-editor Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphocyte Subsets - immunology Lymphocytes Lymphoma Lymphoma - drug therapy Lymphoma - immunology Lymphoma - pathology Lymphomas Male Medical sciences Medicine Medicine & Public Health Middle Aged Myelodysplastic Syndromes - pathology Neutropenia Neutropenia - chemically induced Oncology Other diseases. Hematologic involvement in other diseases Risk factors Rituximab
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!